KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Debt Ratio (2019 - 2025)

Historic Debt Ratio for Rigel Pharmaceuticals (RIGL) over the last 7 years, with Q3 2025 value amounting to 0.25.

  • Rigel Pharmaceuticals' Debt Ratio fell 4254.65% to 0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25, marking a year-over-year decrease of 4254.65%. This contributed to the annual value of 0.36 for FY2024, which is 2841.73% down from last year.
  • Rigel Pharmaceuticals' Debt Ratio amounted to 0.25 in Q3 2025, which was down 4254.65% from 0.29 recorded in Q2 2025.
  • Rigel Pharmaceuticals' Debt Ratio's 5-year high stood at 0.52 during Q3 2023, with a 5-year trough of 0.09 in Q1 2021.
  • Over the past 5 years, Rigel Pharmaceuticals' median Debt Ratio value was 0.34 (recorded in 2025), while the average stood at 0.32.
  • In the last 5 years, Rigel Pharmaceuticals' Debt Ratio soared by 22018.79% in 2022 and then plummeted by 4254.65% in 2025.
  • Rigel Pharmaceuticals' Debt Ratio (Quarter) stood at 0.12 in 2021, then soared by 146.85% to 0.29 in 2022, then soared by 73.07% to 0.51 in 2023, then dropped by 28.42% to 0.36 in 2024, then tumbled by 32.33% to 0.25 in 2025.
  • Its Debt Ratio stands at 0.25 for Q3 2025, versus 0.29 for Q2 2025 and 0.34 for Q1 2025.